The independent source for health policy research, polling, and news.
2,621 - 2,640 of 3,950 Results
Letters sent to Medicare from U.S. Rep. Tom Price, President Trump's pick to run HHS, supported physicians as well as drug or device makers, records show.
Intense, “high touch” care that focuses on housing as well as health care brings down medical costs for the most expensive patients. But it’s been hard to replicate successful programs.
Donald Trump’s pick to run HHS has been under fire for trading health care stocks but at least six senators at his confirmation hearings also own such stocks.
Federal officials release names of insurers who ranked poorly in a recent review of their online directories’ accuracy.
Orphan drugs for rare diseases have helped or saved hundreds of thousands of patients like 2-year-old Luke Whitbeck, but families and insurers are picking up the astronomical cost.
Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives but nearly a third of those products aren’t new or were repurposed multiple times, an investigation shows.
Follow the twists and turns of the orphan drug industry over the past three decades.
Check out all the drugs the FDA has approved to treat rare diseases. You can search by brand name, or by disease, and see familiar names that were first sold on the mass market or all the drugs that won FDA approval to treat more than one rare disease.
The former Congressman championed the Orphan Drug Act decades ago but now he fears it’s being manipulated to make money.
President-elect Donald Trump’s Cabinet pick Tom Price "assisted" a company and campaign donor who tapped executives with an urgent request to donate.
A high-profile whistleblower attorney representing the physician is seeking class action status.
The FDA and other agencies are loosening restrictions on hearing aid sales and opening the door to less expensive, over-the-counter products.
An Obama administration veteran will take the helm of Cal INDEX as it combines with the Inland Empire Health Information Exchange, creating a database covering nearly 17 million patients.
President Barack Obama succeeded where many other presidents failed, but now the fate of the Affordable Care Act rests with President-elect Donald Trump.
Rep. Tom Price advocated on everything from a sperm test to a hot pepper ingredient on behalf of medical interests that included campaign donors.
AARP had sought a preliminary injunction because it argued the new regulations – which allow employers to tie participation to 30 percent of the cost of individual health coverage – could be coercive.
People in these facilities are now guaranteed more flexibility on food and roommate choices, as well as improved procedures for grievances and discharges.
In a number of states, including big ones such as New York and Texas, leading cancer centers aren’t included in insurers’ provider networks.
Investigators claim drugmaker employees met in secret at restaurants, golf outings and at “Girls Night Out” to raise generic drug prices.
Medicare reduced payments to 769 hospitals in the program, punishing facilities that have high rates of patient injuries, including infections, blood clots, falls and bed sores. This year, federal officials also added the prevalence of two dangerous bacteria.
© 2026 KFF